Vaccination with a nanoparticle E7 vaccine can prevent tumor recurrence following surgery in a human papillomavirus head and neck cancer model

High-risk human papillomavirus (HPV) encoding E6/E7-HPV oncogenes are responsible for a subgroup of head and neck squamous-cell carcinoma (HNSCC) and thus therapeutic E7-vaccines may be used to control HPV(+)HNSCC tumors. Herein we investigated the effects of an optimized nanoparticle-conjugated E7...

Descripción completa

Detalles Bibliográficos
Autores principales: Domingos-Pereira, Sonia, Roh, Vincent, Hiou-Feige, Agnès, Galliverti, Gabriele, Simon, Christian, Tolstonog, Genrich V., Nardelli-Haefliger, Denise
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2021
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8049199/
https://www.ncbi.nlm.nih.gov/pubmed/33907631
http://dx.doi.org/10.1080/2162402X.2021.1912473

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8049199/
https://www.ncbi.nlm.nih.gov/pubmed/33907631
http://dx.doi.org/10.1080/2162402X.2021.1912473

Ejemplares similares